デフォルト表紙
市場調査レポート
商品コード
1327585

経カテーテル僧帽弁移植術市場(金額、数量、ASP):セグメント別規模、シェア、動向およびSWOT分析、法規制および償還動向、手技、2033年までの予測

Transcatheter Mitral Valve Implantation Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033

出版日: | 発行: GlobalData | ページ情報: 英文 | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=160.10円
経カテーテル僧帽弁移植術市場(金額、数量、ASP):セグメント別規模、シェア、動向およびSWOT分析、法規制および償還動向、手技、2033年までの予測
出版日: 2023年06月27日
発行: GlobalData
ページ情報: 英文
納期: 即納可能 即納可能とは
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

経カテーテル僧帽弁移植術(TMVI)は、大動脈瘤や解離の治療に使用されます。大動脈瘤は胸部大動脈(胸部大動脈瘤-TAA)と腹部大動脈(腹部大動脈瘤-AAA)の両方に発生する可能性があります。大動脈瘤は大動脈の壁が弱くなることで発生し、その結果、大動脈の壁が大きく膨らんで弱くなります。

腹部経カテーテル的僧帽弁留置術(TMVI)は、低侵襲手術で大動脈の一部を補強することで、腹部大動脈瘤の治療に用いられます。胸部経カテーテル的僧帽弁移植術(TMVI)は、低侵襲手術で大動脈の一部を補強することにより、胸部大動脈瘤を治療するために使用されます。レッグエクステンションは、ステントグラフトの長さを延長するために、ステントグラフトとともに使用される追加エクステンションです。

当レポートは、世界の経カテーテル僧帽弁移植術市場について詳細に考察し、市場における競合情勢、SWOT分析、2033年までの市場予測、COVID-19の影響、地域、国別の動向などを提供しています。

目次

現在上市されている経カテーテル僧帽弁移植術と競合情勢

  • 主要な業界動向の洞察
  • 経カテーテル僧帽弁移植術のセグメント別総市場収益と2015年~2033年の市場展望
  • セグメント別の手技総数、台数、平均販売価格、市場価値に関する詳細データ

世界、地域、国別の洞察

  • 経カテーテル僧帽弁移植術市場のSWOT分析
  • 経カテーテル僧帽弁移植術市場に関する競合力学の洞察と動向
  • 国別の医療制度の概要
  • 国別の償還政策
  • 国別の医療技術に関する規制の状況
目次
Product Code: GDME681MM

Abstract

Transcatheter Mitral Valve Implantation Market Size (Value, Volume, ASP) by Segments, Share, Trend and SWOT Analysis, Regulatory and Reimbursement Landscape, Procedures, and Forecast to 2033 is built to visualize quantitative market trends within Cardiovascular Devices therapeutic area.

The model discusses in detail the impact of COVID-19 on Transcatheter Mitral Valve Implantation (TMVI) market for the year 2020 and beyond. Transcatheter Mitral Valve Implantation (TMVI) are used to treat aortic aneurysms and dissections. Aortic aneurysms can occur in both the thoracic aorta (Thoracic Aortic Aneurysms - TAA) and abdominal aorta (Abdominal Aortic Aneurysms - AAA). Aortic aneurysms occur when the walls of the aorta weaken, resulting in a large swelling and weakening of the aortic wall.

Abdominal Transcatheter Mitral Valve Implantation (TMVI) are used to treat abdominal aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. Thoracic Transcatheter Mitral Valve Implantation (TMVI) are used to treat thoracic aortic aneurysms by reinforcing a part of the aorta using a minimally invasive procedure. Leg extensions are additional extensions which are used in conjunction with the stent graft to extend the length of the stent graft.

Each of the covered 27 country's color-coded and fully-sourced market models are equipped with epidemiology based indications with procedure volumes. To increase the data transparency, the interactive excel deliverable covers installed base, new sales volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Transcatheter Mitral Valve Implantation (TMVI) market and evolving competitive landscape -

  • Insightful review of the key industry trends.
  • Annualized total Transcatheter Mitral Valve Implantation (TMVI) market revenue by segment and market outlooks from 2015-2033.
  • Granular data on total procedures, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

  • Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
  • SWOT analysis for Transcatheter Mitral Valve Implantation (TMVI) market.
  • Competitive dynamics insights and trends provided Transcatheter Mitral Valve Implantation (TMVI) market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

  • Country specific overview of the healthcare system.
  • Country specific reimbursement policies.
  • Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Abbott Laboratories

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, Sweden, Switzerland, Austria, Belgium, Finland, Norway, Poland, and Portugal.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

  • CMO executives who must have deep understanding of the Transcatheter Mitral Valve Implantation (TMVI) marketplace to make strategic planning and investment decisions.
  • Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
  • Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

  • Understand the impact of COVID-19 on Transcatheter Mitral Valve Implantation market.
  • Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
  • Develop business strategies by understanding the trends shaping and driving Transcatheter Mitral Valve Implantation market.
  • Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Transcatheter Mitral Valve Implantation market in the future.
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
  • Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
  • Track device sales in the global and country-specific Transcatheter Mitral Valve Implantation market from 2015-2033.
  • Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.